annual EBITDA:
-$204.15M-$11.99M(-6.24%)Summary
- As of today (June 10, 2025), ABCL annual EBITDA is -$204.15 million, with the most recent change of -$11.99 million (-6.24%) on December 31, 2024.
- During the last 3 years, ABCL annual EBITDA has fallen by -$443.30 million (-185.36%).
- ABCL annual EBITDA is now -178.47% below its all-time high of $260.17 million, reached on December 31, 2022.
Performance
ABCL EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly EBITDA:
-$51.90M+$3.41M(+6.16%)Summary
- As of today (June 10, 2025), ABCL quarterly EBITDA is -$51.90 million, with the most recent change of +$3.41 million (+6.16%) on March 31, 2025.
- Over the past year, ABCL quarterly EBITDA has dropped by -$7.05 million (-15.72%).
- ABCL quarterly EBITDA is now -122.07% below its all-time high of $235.12 million, reached on March 31, 2022.
Performance
ABCL quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBITDA:
-$211.20M-$7.05M(-3.45%)Summary
- As of today (June 10, 2025), ABCL TTM EBITDA is -$211.20 million, with the most recent change of -$7.05 million (-3.45%) on March 31, 2025.
- Over the past year, ABCL TTM EBITDA has dropped by -$28.57 million (-15.64%).
- ABCL TTM EBITDA is now -156.68% below its all-time high of $372.64 million, reached on September 30, 2022.
Performance
ABCL TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
ABCL EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -6.2% | -15.7% | -15.6% |
| 3 y3 years | -185.4% | -122.1% | -168.3% |
| 5 y5 years | -10000.0% | -10000.0% | -10000.0% |
ABCL EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -178.5% | at low | -122.1% | +6.2% | -156.7% | at low |
| 5 y | 5-year | -178.5% | at low | -122.1% | +6.2% | -156.7% | at low |
| alltime | all time | -178.5% | at low | -122.1% | +6.2% | -156.7% | at low |
ABCL EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | -$51.90M(-6.2%) | -$211.20M(+3.5%) |
| Dec 2024 | -$204.15M(+6.2%) | -$55.31M(+6.6%) | -$204.15M(+0.9%) |
| Sep 2024 | - | -$51.88M(-0.4%) | -$202.41M(+3.7%) |
| Jun 2024 | - | -$52.11M(+16.2%) | -$195.18M(+6.9%) |
| Mar 2024 | - | -$44.85M(-16.3%) | -$182.63M(-5.0%) |
| Dec 2023 | -$192.16M(-173.9%) | -$53.57M(+20.0%) | -$192.16M(+20.6%) |
| Sep 2023 | - | -$44.65M(+12.9%) | -$159.33M(+134.1%) |
| Jun 2023 | - | -$39.56M(-27.3%) | -$68.07M(+132.1%) |
| Mar 2023 | - | -$54.38M(+162.2%) | -$29.33M(-111.3%) |
| Dec 2022 | $260.17M | -$20.74M(-144.5%) | $260.17M(-30.2%) |
| Sep 2022 | - | $46.61M(-5784.5%) | $372.64M(+21.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2022 | - | -$820.00K(-100.3%) | $306.51M(-0.9%) |
| Mar 2022 | - | $235.12M(+156.3%) | $309.16M(+29.2%) |
| Dec 2021 | $239.15M(+41.0%) | $91.73M(-570.2%) | $239.23M(-22.8%) |
| Sep 2021 | - | -$19.51M(-1167.3%) | $309.70M(-6.1%) |
| Jun 2021 | - | $1.83M(-98.9%) | $329.72M(-1.9%) |
| Mar 2021 | - | $165.19M(+1.8%) | $335.97M(+97.2%) |
| Dec 2020 | $169.62M(<-9900.0%) | $162.20M(>+9900.0%) | $170.34M(+2307.8%) |
| Sep 2020 | - | $506.00K(-93.7%) | $7.07M(+7.7%) |
| Jun 2020 | - | $8.08M(-1910.8%) | $6.57M(-535.6%) |
| Mar 2020 | - | -$446.00K(-58.0%) | -$1.51M(+42.0%) |
| Dec 2019 | -$155.00K(-110.8%) | -$1.06M | -$1.06M |
| Dec 2018 | $1.44M | - | - |
FAQ
- What is AbCellera Biologics annual EBITDA?
- What is the all time high annual EBITDA for AbCellera Biologics?
- What is AbCellera Biologics annual EBITDA year-on-year change?
- What is AbCellera Biologics quarterly EBITDA?
- What is the all time high quarterly EBITDA for AbCellera Biologics?
- What is AbCellera Biologics quarterly EBITDA year-on-year change?
- What is AbCellera Biologics TTM EBITDA?
- What is the all time high TTM EBITDA for AbCellera Biologics?
- What is AbCellera Biologics TTM EBITDA year-on-year change?
What is AbCellera Biologics annual EBITDA?
The current annual EBITDA of ABCL is -$204.15M
What is the all time high annual EBITDA for AbCellera Biologics?
AbCellera Biologics all-time high annual EBITDA is $260.17M
What is AbCellera Biologics annual EBITDA year-on-year change?
Over the past year, ABCL annual EBITDA has changed by -$11.99M (-6.24%)
What is AbCellera Biologics quarterly EBITDA?
The current quarterly EBITDA of ABCL is -$51.90M
What is the all time high quarterly EBITDA for AbCellera Biologics?
AbCellera Biologics all-time high quarterly EBITDA is $235.12M
What is AbCellera Biologics quarterly EBITDA year-on-year change?
Over the past year, ABCL quarterly EBITDA has changed by -$7.05M (-15.72%)
What is AbCellera Biologics TTM EBITDA?
The current TTM EBITDA of ABCL is -$211.20M
What is the all time high TTM EBITDA for AbCellera Biologics?
AbCellera Biologics all-time high TTM EBITDA is $372.64M
What is AbCellera Biologics TTM EBITDA year-on-year change?
Over the past year, ABCL TTM EBITDA has changed by -$28.57M (-15.64%)